NIH-funded research R21 grant

Improving CAR-T cell therapy for brain tumors using focused ultrasound

Official title: Novel approaches to enrich CAR-T cell Therapy in brain tumors using focused ultrasound

Funded at Univ of North Carolina Chapel Hill · NIH-10997390 · Data updated 2026-11-12

This study is looking at how using focused ultrasound can help CAR-T cell therapy work better for people with glioblastoma, a type of brain tumor, by making it easier for the treatment to reach and attack the tumor cells in the brain.

More CAR-T Cell Therapy research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2025
Funding year2025
Award (this year)$211,773
NIH project number5R21CA286897-02
Project IDNIH-10997390 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with glioblastoma who are seeking innovative treatment options.

Less likely to help

Patients with brain tumors other than glioblastoma or those who are not eligible for CAR-T cell therapy may not benefit from this research.

What this research studies

This research investigates how focused ultrasound (FUS) can enhance the effectiveness of CAR-T cell therapy for treating glioblastoma, a type of brain tumor. By using FUS, the researchers aim to temporarily disrupt the blood-brain barrier, allowing CAR-T cells to better penetrate brain tissue and target tumor cells. The study involves advanced biomedical engineering techniques and aims to improve the delivery of these innovative therapies to patients with brain tumors. The approach is based on promising early studies that have shown the potential of FUS in enhancing drug delivery to the brain.

Why it matters

Potential benefit: If successful, this research could significantly improve treatment outcomes for patients with glioblastoma by enhancing the effectiveness of CAR-T cell therapy.

How similar studies have gone: Other studies have shown success with focused ultrasound in enhancing drug delivery to the brain, making this approach promising yet still innovative.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Dayton, Paul a — Univ of North Carolina Chapel Hill
  • Study coordinator: Dayton, Paul a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.